Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The new therapeutic landscape in multiple sclerosis: exciting times and new perspectives.
[Rare case of noeffective therapy with natalizumab (tisabri) in a female patient with multiple sclerosis and neutralizing antibodies to the drug.]
The effects of identification with a support group on the mental health of people with multiple sclerosis.
Validity of the Dynamic Gait Index in People With Multiple Sclerosis.
Evidence for the efficacy and effectiveness of THC-CBD oromucosal spray in symptom management of patients with spasticity due to multiple sclerosis.
Isolated Brain Stem Lesion in Children: Is It Acute Disseminated Encephalomyelitis or Not?
Matrix metalloproteinase-3 in the central nervous system: a look on the bright side.
Multiple sclerosis: Spinal cord MRI indices correlate with outcome in MS.
Internet-based self-help treatment for depression in multiple sclerosis: study protocol of a randomized controlled trial.
The clinico-radiological paradox in multiple sclerosis: novel implications of lesion size.
The fatigue-motor performance paradox in multiple sclerosis.
M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination.
Autoantibody biomarkers in childhood-acquired demyelinating syndromes: results from a national surveillance cohort.
Atypical hereditary spastic paraplegia mimicking multiple sclerosis associated with a novel SPG11 mutation.
Novel Marmoset (Callithrix jacchus) Model of Human Herpesvirus 6A and 6B Infections: Immunologic, Virologic and Radiologic Characterization.
Work capacity and health-related quality of life among individuals with multiple sclerosis reduced by fatigue: a cross-sectional study.
Pediatric Urinary Retention in the Emergency Department: A Concerning Symptom with Etiology Outside the Bladder.
Leuprolide Acetate, a GnRH Agonist, Improves Experimental Autoimmune Encephalomyelitis: A Possible Therapy for Multiple Sclerosis.
Cerebral regulatory T cells restrain microglia/macrophage-mediated inflammatory responses via IL-10.
Novel insights into the development and maintenance of the blood-brain barrier.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Simvastatin in Relapsing Remitting Multiple Sclerosis (RRMS) Patients Using Avonex Compared to Placebo (irmsrct)
Multiple sclerosis: KIR4.1 as an autoantigen in MS-new questions raised.
MRI Study: Objective Olfactory Function and CNS Pathologies in Patients with Multiple Sclerosis.
The pharmacokinetics of glatiramer acetate for multiple sclerosis treatment.
Pages
« first
‹ previous
…
327
328
329
330
331
332
333
334
335
…
next ›
last »